8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine

C112H151ClFN31O11 — CID 158838158

IUPAC8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine
SMILESCCOCC.CCOCC.CCOCC.CCOCC.CCOCC.COC(=O)c1cnc(NC2CCC(Nc3cc(N)cc4nccnc34)CC2)cn1.Nc1cc(OC2CCC(Nc3cc(Cl)ncn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3cnccn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncc(F)cn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncccn3)CC2)c2nccnc2c1
InChIInChI=1S/C20H23N7O2.C18H19ClN6O.C18H19FN6O.2C18H20N6O.5C4H10O/c1-29-20(28)17-10-25-18(11-24-17)27-14-4-2-13(3-5-14)26-16-9-12(21)8-15-19(16)23-7-6-22-15;19-16-9-17(24-10-23-16)25-12-1-3-13(4-2-12)26-15-8-11(20)7-14-18(15)22-6-5-21-14;19-11-9-23-18(24-10-11)25-13-1-3-14(4-2-13)26-16-8-12(20)7-15-17(16)22-6-5-21-15;19-12-10-15-17(21-9-8-20-15)16(11-12)25-14-4-2-13(3-5-14)24-18-22-6-1-7-23-18;19-12-9-15-18(23-8-7-21-15)16(10-12)25-14-3-1-13(2-4-14)24-17-11-20-5-6-22-17;5*1-3-5-4-2/h6-11,13-14,26H,2-5,21H2,1H3,(H,25,27);5-10,12-13H,1-4,20H2,(H,23,24,25);5-10,13-14H,1-4,20H2,(H,23,24,25);1,6-11,13-14H,2-5,19H2,(H,22,23,24);5-11,13-14H,1-4,19H2,(H,22,24);5*3-4H2,1-2H3
InChIKeyIXWYISVPZOKEAR-UHFFFAOYSA-N
MW2162.10 g/mol
LogP19.85
Rot. Bonds31

About 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine

8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine (PubChem CID 158838158) has the molecular formula C112H151ClFN31O11 and a molecular weight of 2162.10 g/mol. Its IUPAC name is 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine.

Molecular Properties

Compound Name8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine
PubChem CID158838158
Molecular FormulaC112H151ClFN31O11
Molecular Weight2162.10 g/mol
Exact Mass2160.19
IUPAC Name8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine
SMILESCCOCC.CCOCC.CCOCC.CCOCC.CCOCC.COC(=O)c1cnc(NC2CCC(Nc3cc(N)cc4nccnc34)CC2)cn1.Nc1cc(OC2CCC(Nc3cc(Cl)ncn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3cnccn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncc(F)cn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncccn3)CC2)c2nccnc2c1
InChIInChI=1S/C20H23N7O2.C18H19ClN6O.C18H19FN6O.2C18H20N6O.5C4H10O/c1-29-20(28)17-10-25-18(11-24-17)27-14-4-2-13(3-5-14)26-16-9-12(21)8-15-19(16)23-7-6-22-15;19-16-9-17(24-10-23-16)25-12-1-3-13(4-2-12)26-15-8-11(20)7-14-18(15)22-6-5-21-14;19-11-9-23-18(24-10-11)25-13-1-3-14(4-2-13)26-16-8-12(20)7-15-17(16)22-6-5-21-15;19-12-10-15-17(21-9-8-20-15)16(11-12)25-14-4-2-13(3-5-14)24-18-22-6-1-7-23-18;19-12-9-15-18(23-8-7-21-15)16(10-12)25-14-3-1-13(2-4-14)24-17-11-20-5-6-22-17;5*1-3-5-4-2/h6-11,13-14,26H,2-5,21H2,1H3,(H,25,27);5-10,12-13H,1-4,20H2,(H,23,24,25);5-10,13-14H,1-4,20H2,(H,23,24,25);1,6-11,13-14H,2-5,19H2,(H,22,23,24);5-11,13-14H,1-4,19H2,(H,22,24);5*3-4H2,1-2H3
InChIKeyIXWYISVPZOKEAR-UHFFFAOYSA-N
XLogP19.85
TPSA569.45 Ų
H-Bond Donors11
H-Bond Acceptors42
Rotatable Bonds31
Heavy Atoms156
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002162.10
LogP ≤ 519.85
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine?
The IUPAC name of 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine (CID 158838158) is 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine.
What is the SMILES notation for 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine?
The canonical SMILES for 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine is CCOCC.CCOCC.CCOCC.CCOCC.CCOCC.COC(=O)c1cnc(NC2CCC(Nc3cc(N)cc4nccnc34)CC2)cn1.Nc1cc(OC2CCC(Nc3cc(Cl)ncn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3cnccn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncc(F)cn3)CC2)c2nccnc2c1.Nc1cc(OC2CCC(Nc3ncccn3)CC2)c2nccnc2c1.
What is the InChIKey of 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine?
The InChIKey is IXWYISVPZOKEAR-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H23N7O2.C18H19ClN6O.C18H19FN6O.2C18H20N6O.5C4H10O/c1-29-20(28)17-10-25-18(11-24-17)27-14-4-2-13(3-5-14)26-16-9-12(21)8-15-19(16)23-7-6-22-15;19-16-9-17(24-10-23-16)25-12-1-3-13(4-2-12)26-15-8-11(20)7-14-18(15)22-6-5-21-14;19-11-9-23-18(24-10-11)25-13-1-3-14(4-2-13)26-16-8-12(20)7-15-17(16)22-6-5-21-15;19-12-10-15-17(21-9-8-20-15)16(11-12)25-14-4-2-13(3-5-14)24-18-22-6-1-7-23-18;19-12-9-15-18(23-8-7-21-15)16(10-12)25-14-3-1-13(2-4-14)24-17-11-20-5-6-22-17;5*1-3-5-4-2/h6-11,13-14,26H,2-5,21H2,1H3,(H,25,27);5-10,12-13H,1-4,20H2,(H,23,24,25);5-10,13-14H,1-4,20H2,(H,23,24,25);1,6-11,13-14H,2-5,19H2,(H,22,23,24);5-11,13-14H,1-4,19H2,(H,22,24);5*3-4H2,1-2H3.
What are the key properties of 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine?
8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine has a molecular weight of 2162.10 g/mol, XLogP of 19.85, 31 rotatable bonds, 11 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 8-[4-[(6-chloropyrimidin-4-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;ethoxyethane;8-[4-[(5-fluoropyrimidin-2-yl)amino]cyclohexyl]oxyquinoxalin-6-amine;methyl 5-[[4-[(7-aminoquinoxalin-5-yl)amino]cyclohexyl]amino]pyrazine-2-carboxylate;8-[4-(pyrazin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine;8-[4-(pyrimidin-2-ylamino)cyclohexyl]oxyquinoxalin-6-amine is sourced from PubChem (CID 158838158), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).